Xiamen Comfort Science&Technology Group Co., Ltd

SZSE:002614.SZ

7.29 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007
Revenue 5,030.466,024.3377,926.7227,049.1585,276.2715,447.0314,293.8093,451.3832,830.7272,811.2582,229.9781,771.661,886.841,829.8521,302.6921,188.4721,087.666
Cost of Revenue 3,165.5574,082.5355,559.4734,631.3543,312.6863,472.2112,705.2742,216.7481,890.6561,906.1731,743.2311,471.6761,527.7321,470.6491,044.167984.913881.94
Gross Profit 1,864.9031,941.8012,367.2492,417.8051,963.5851,974.8191,588.5351,234.635940.071905.084486.747299.984359.108359.204258.525203.559205.726
Gross Profit Ratio 0.3710.3220.2990.3430.3720.3630.370.3580.3320.3220.2180.1690.190.1960.1980.1710.189
Reseach & Development Expenses 218.548246.655289.42268.785226.869183.43310.61912.53619.88317.09911.68211.02600000
General & Administrative Expenses 99.18199.317142.503112.771108.346104.207100.77481.22166.1769.65140.49739.135153.698122.77683.75777.24967.384
Selling & Marketing Expenses 1,057.871,105.5321,171.839994.9911,040.785996.376813.403600.131445.499489.579210.288111.92269.85770.5458.22936.22329.786
SG&A 1,157.051,204.8491,314.3411,107.7621,149.131,100.583914.176681.352511.669559.23250.785151.057223.555193.316141.986113.47397.17
Other Expenses -1.616293.077305.549313.959223.144-0.135-6.33826.41812.358-10.71318.3648.3536.7665.0433.3720.983.502
Operating Expenses 1,653.5661,744.5811,909.3111,690.5071,599.1431,555.7121,222.4861,005.05823.156795.737428.948304.058232.829196.956146.008114.9398.315
Operating Income 150.132276.508534.512527.587346.733522.517399.334293.707196.391147.471105.53229.263152.593169.113104.88754.062116.706
Operating Income Ratio 0.030.0460.0670.0750.0660.0960.0930.0850.0690.0520.0470.0170.0810.0920.0810.0450.107
Total Other Income Expenses Net -57.834-108.808-6.908-10.266-1.119105.08737.36780.56890.88554.3464.11840.532.9411.908-4.258-33.58712.798
Income Before Tax 153.504167.7527.605517.321345.614524.194403.416310.153207.8163.688121.91836.425159.219174.155108.25955.042120.208
Income Before Tax Ratio 0.0310.0280.0670.0730.0660.0960.0940.090.0730.0580.0550.0210.0840.0950.0830.0460.111
Income Tax Expense 39.11356.49257.77174.68265.47481.38747.94944.55425.75224.99217.5349.48920.77821.07814.2896.78512.106
Net Income 103.203102.023458.358439.276288.978439.122345.18251.03180.554140.218104.34727.391138.441153.07793.9746.02488.175
Net Income Ratio 0.0210.0170.0580.0620.0550.0810.080.0730.0640.050.0470.0150.0730.0840.0720.0390.081
EPS 0.170.160.740.770.520.790.630.460.330.260.190.0490.320.380.230.110.22
EPS Diluted 0.170.160.680.680.510.770.620.450.330.260.190.0490.320.380.230.110.22
EBITDA 556.138547.002938.691726.909494.397521.303462.349434.66288.6232.722155.19469.461183.156185.597124.719118.00887.494
EBITDA Ratio 0.1110.0910.1180.1030.0940.0960.1080.1260.1020.0830.070.0390.0970.1010.0960.0990.08